Dr. Sinclair has been a member of our Board of Directors since December 2018. Since
2008, Dr. Sinclair has held various positions at Abingworth LLP, a life sciences
investment group, where he is currently a Partner and Portfolio Manager. Dr. Sinclair is
a member of the Institute of Chartered Accountants in England and Wales and received
a Ph.D. in chemistry and genetic engineering at the BBSRC Institute of Plant Science,
Norwich, and a B.Sc. in microbiology from King’s College London.Andrew Sinclair, PhD – Soleno
Developing novel therapeutics for the treatment of rare diseases.